Chelsea Worldwide Inc. Contracts & Agreements
50 Contracts & Agreements
- Business Finance (33 contracts)
- Business Operations (3)
- Human Resources (7)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (4)
- Note Purchase Agreement, dated December 17, 2024, by and among Clene Inc., Kensington Clene 2024 LLC, 4Life Research, LLC and La Scala Investments, LLC (Filed With SEC on December 20, 2024)
- Third Amendment to Supplement to Loan and Security Agreement, dated September 30, 2024, by and among Avenue Venture Opportunities Fund, L.P., Clene Inc. and Clene Nanomedicine, Inc (Filed With SEC on September 30, 2024)
- Form of Amended and Restated Warrant to Purchase Shares of Stock of Clene Inc (Filed With SEC on September 30, 2024)
- Placement Agency Agreement, dated September 30, 2024, by and between Clene Inc. and Canaccord Genuity LLC (Filed With SEC on September 30, 2024)
- Form of Affiliate Securities Purchase Agreement, dated September 30, 2024 (Filed With SEC on September 30, 2024)
- Form of Private Securities Purchase Agreement, dated September 30, 2024 (Filed With SEC on September 30, 2024)
- Form of Registered Securities Purchase Agreement, dated September 30, 2024 (Filed With SEC on September 30, 2024)
- Form of Restricted Warrant (Filed With SEC on September 30, 2024)
- Form of Restricted Pre-Funded Warrant (Filed With SEC on September 30, 2024)
- Form of Registered Pre-Funded Warrant (Filed With SEC on September 30, 2024)
- Clene Inc. Amended 2020 Stock Plan (Filed With SEC on May 30, 2024)
- Amended and Restated License Agreement, dated April 25, 2024, between Clene Nanomedicine, Inc. and 4Life Research, LLC (Filed With SEC on April 26, 2024)
- Amended and Restated Exclusive Supply Agreement, dated April 25, 2024, between Clene Nanomedicine, Inc. and 4Life Research, LLC (Filed With SEC on April 26, 2024)
- FDP Cost Reimbursement Subaward, dated April 3, 2024, by and between Clene Nanomedicine, Inc. and the Trustees of Colombia University in the City of New York (Filed With SEC on April 9, 2024)
- Description of Securities of the Registrant (Filed With SEC on March 13, 2024)
- Second Amendment to Supplement to Loan and Security Agreement, dated June 27, 2023, by and among Avenue Venture Opportunities Fund, L.P., Clene Inc., and Clene Nanomedicine, Inc (Filed With SEC on June 30, 2023)
- Form of Avenue Venture Opportunities Fund, L.P. Warrant to Purchase Shares of Common Stock (Filed With SEC on June 30, 2023)
- Form of Tranche B Warrant (Filed With SEC on June 16, 2023)
- Form of Tranche A Warrant (Filed With SEC on June 16, 2023)
- Underwriting Agreement, datedJune 16, 2023, by and between Clene Inc. and Canaccord Genuity LLC (Filed With SEC on June 16, 2023)
- Clene Inc. Amended 2020 Stock Plan (Filed With SEC on May 11, 2023)
- Description of Securities of the Registrant (Filed With SEC on March 13, 2023)
- Registration Rights Agreement, dated March 3, 2023, by and between Clene Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 3, 2023)
- Purchase Agreement, dated March 3, 2023, by and between Clene Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 3, 2023)
- Amendment No. 1 to Equity Distribution Agreement, dated December 19, 2022, by and among Clene Inc. and Canaccord Genuity LLC and Oppenheimer & Co. Inc (Filed With SEC on December 20, 2022)
- Promissory Note, dated December 8, 2022, by Clene Nanomedicine, Inc. to the Department of Housing and Community Development, a principal department of the State of Maryland (Filed With SEC on December 14, 2022)
- Loan Agreement, dated December 8, 2022, by and between the Department of Housing and Community Development, a principal department of the State of Maryland, and Clene... (Filed With SEC on December 14, 2022)
- Form of Securities Purchase Agreement, dated October 31, 2022, by and among Clene Inc. and the purchasers signatory thereto (Filed With SEC on October 31, 2022)
- Second Amendment to Loan and Security Agreement, dated August 9, 2022, by and between Clene Inc., Clene Nanomedicine, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 15, 2022)
- Amended and Restated Promissory Note, dated July August 5, 2022, by Clene Nanomedicine, Inc. to the Department of Housing and Community Development, a principal department of the... (Filed With SEC on August 15, 2022)
- Promissory Note, dated May 17, 2022, by Clene Nanomedicine, Inc. to the Department of Housing of Community Development, a principal department of the State of Maryland (Filed With SEC on May 19, 2022)
- Disbursement Agreement, dated May 17, 2022, by and between Clene Nanomedicine, Inc. and the Department of Housing of Community Development, a principal department of the State of... (Filed With SEC on May 19, 2022)
- Security Agreement, dated May 17, 2022, by Clene Nanomedicine, Inc. in favor of the Department of Housing of Community Development, a principal department of the State of Maryland (Filed With SEC on May 19, 2022)
- Equity Distribution Agreement, dated April 14, 2022, by and among Clene Inc. and Canaccord Genuity LLC and Oppenheimer & Co. Inc (Filed With SEC on April 14, 2022)
- Amendment to Supplement to Loan and Security Agreement, dated as of February 11, 2022, among Clene Inc., Clene Nanomedicine, Inc., and Avenue Venture Opportunities Fund, L.P (Filed With SEC on March 11, 2022)
- Description of Securities of the Registrant (Filed With SEC on March 11, 2022)
- Amendment to Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Dr. Robert Glanzman (Filed With SEC on February 2, 2022)
- Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Morgan Brown (Filed With SEC on February 2, 2022)
- Retention and Separation Agreement and General Release, dated February 1, 2022, by and between Clene Inc. and Dr. Tae Heum (Ted) Jeong (Filed With SEC on February 2, 2022)
- Form of Executive Employment Agreement (Filed With SEC on February 2, 2022)
- Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Robert Etherington (Filed With SEC on February 2, 2022)
- Lease Agreement, dated as of August 10, 2021, between Clene Nanomedicine, Inc. and Upper Chesapeake Flex One, LLC (Filed With SEC on August 11, 2021)
- Lease Agreement, dated as of August 10, 2021, between Clene Nanomedicine, Inc. and 100 Chesapeake Blvd LLC (Filed With SEC on August 11, 2021)
- First Amendment to the Loan and Security Agreement, dated as of June 30, 2021, between Clene Inc., Clene Nanomedicine, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 9, 2021)
- Form of Subscription Agreement (Filed With SEC on May 24, 2021)
- Form of Avenue Venture Opportunities Fund, L.P. Warrant to Purchase Shares of Stock of Clene Inc (Filed With SEC on May 24, 2021)
- Supplement to the Loan and Security Agreement, dated as of May 21, 2021, among Client Inc., Clene Nanomedicine, Inc., and Avenue Venture Opportunities Fund, L.P (Filed With SEC on May 24, 2021)
- Loan and Security Agreement, dated as of May 21, 2021, between Clene Inc., Clene Nanomedicine, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on May 24, 2021)
- Clene Inc. Board of Directors Compensation Program (Filed With SEC on April 22, 2021)
- 2020 Equity Incentive Plan (Filed With SEC on January 5, 2021)
